GSN and systemic lupus erythematosus: Gelsolin has been shown to play a role in inflammation and specially inflammatory autoimmune disease, with studies suggesting potential clinical applications for plasma gelsolin in diagnosis and disease activity evaluation as patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) have significantly decreased plasma gelsolin levels compared to healthy controls [34,35].